You just read:

Foamix Announces Publication of AMZEEQ™ (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology

News provided by

Foamix Pharmaceuticals Ltd.

Nov 04, 2019, 08:01 ET